- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05981690
Therapist Guided, Parent-led, Cognitive Behavioural Therapy (CBT) for Preadolescent Children With Obsessive Compulsive Disorder (OCD)
This preliminary study aims to examine the outcomes from a therapist guided, parent-led, CBT treatment for preadolescent children (aged 5 to 12 years old) with OCD.
Specifically, this study aims to:
- Examine outcomes for children who receive the therapist guided, parent-led, CBT treatment for preadolescent children with OCD.
- Examine parents' experiences and views about the acceptability of the treatment approach.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study adapted an existing therapist guided, parent-led CBT intervention for children with anxiety difficulties, to ensure suitability for preadolescent children with OCD.
This preliminary study aims to examine the outcomes from a therapist guided, parent-led, CBT treatment for preadolescent children (aged 5 to 12 years old) with OCD.
Specifically, this study aims to:
- Examine outcomes for children who receive the therapist guided, parent-led, CBT treatment for preadolescent children with OCD.
- Examine parents' experiences and views about the acceptability of the treatment approach.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
UK
-
Reading, UK, United Kingdom, RG6 6BZ
- University of Reading
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Children
Inclusion criteria:
- Aged 5 to 12 years old (when parents/carers complete the baseline questionnaires).
- Diagnosis of OCD (identified from the ADIS-P).
- UK-resident. Parents
Inclusion criteria:
- Parent/legal guardian of the child.
- UK resident.
Exclusion Criteria:
Children
Exclusion criteria:
Comorbid condition, which is likely to interfere with treatment delivery, for example:
- Established Autism Spectrum Condition (ASC).
- Suspected ASC (indicated by exceeding the threshold of 15 on the Social Communication Questionnaire and where a diagnosis of ASC has not been ruled out by a medical professional).
- Profound learning difficulty (evidenced by attending a specialist school).
Risk and/or safeguarding concerns, which are paramount and would interfere with treatment delivery, for example:
- Suicidal intent.
- Recurrent or potentially life limiting self-harm.
- Significant safeguarding concerns (i.e., if the child has a child protection plan and/or is on the child protection register, and/or the research team consider the child to be suffering, or likely to suffer, significant harm).
- If children have been prescribed psychotropic medication, the dosage must have been stable for two months.
- Children who are currently receiving other psychological support/interventions delivered by a mental health professional.
Parents
Exclusion criteria:
- Significant intellectual impairment that is likely to interfere with treatment delivery.
- Unable to access or understand written English language materials needed for the intervention.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Therapist guided, parent-led CBT for preadolescent children with OCD
6 to 8 sessions of therapist guided, parent-led CBT for preadolescent children with OCD
|
This treatment was adapted from an existing evidence based therapist guided parent-led CBT intervention for preadolescent children with anxiety difficulties.
It consists of 6 to 8 treatment individual treatment sessions where parents learn CBT techniques to apply at home with their child
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Children's Yale Brown Obsessive Compulsive Scale (CY-BOCS)
Time Frame: Change from pre-baseline phase, within one-week post-treatment, one-month follow-up
|
Diagnostic interview.
Higher scores indicate higher severity of OCD
|
Change from pre-baseline phase, within one-week post-treatment, one-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety Disorder Interview Schedule - Parent Report (ADIS-P)
Time Frame: Change from pre-baseline phase, within one-week post-treatment, one-month follow-up
|
Diagnostic interview.
Indicates presence/absence of anxiety, OCD, and externalising difficulties.
Higher severity scores indicate greater severity of difficulties.
|
Change from pre-baseline phase, within one-week post-treatment, one-month follow-up
|
Children's Obsessional Compulsive Inventory - Revised - Parent Report (ChOCI-R-P)
Time Frame: Weekly during baseline and intervention phase; one month follow up
|
Symptom measure.
Higher scores indicate greater OCD symptoms and impairment.
|
Weekly during baseline and intervention phase; one month follow up
|
Family Accommodation Scale - FAS
Time Frame: Weekly during baseline and intervention phase; one month follow up
|
Symptom measure.
Higher scores indicate greater levels of family accommodation of OCD.
|
Weekly during baseline and intervention phase; one month follow up
|
Goal Based Outcomes - GBOs
Time Frame: Weekly during intervention phase; one month follow up
|
Families identify up to 3 personalised goals to work towards during the intervention.
Goals are rated weekly by the parent form 0 (no goal progress) to 10 (goal achieved)
|
Weekly during intervention phase; one month follow up
|
Session Rating Scale- SRS
Time Frame: Weekly during intervention phase; one month follow-up
|
Therapeutic alliance/treatment acceptability.
Higher scores indicate greater acceptability.
|
Weekly during intervention phase; one month follow-up
|
Treatment acceptability questions
Time Frame: one month follow-up
|
Treatment acceptability.
6 questionnaire items on a Likert scale from strongly disagree to strongly agree.
4 open ended questions regarding treatment acceptability.
|
one month follow-up
|
Items assessing parent knowledge of OCD, how to help their child, and confidence to help child
Time Frame: Weekly during baseline and intervention phase; one month follow up
|
3 questionnaire items devised by study authors to assess parents' report of their knowledge and confidence to help their child to overcome OCD.
Items scored from 0 (no new learning) to 5 (learned a lot)
|
Weekly during baseline and intervention phase; one month follow up
|
Items assessing how much children have learned new information about their fears/ability to cope in feared situations
Time Frame: Weekly during intervention phase; one month follow up
|
2 questionnaire items devised by study authors to assess parents' perceptions of whether their child had learned new information about their fears and their ability to cope in feared situations, without performing their compulsions.
Items scored from 0 (no new learning) to 5 (learned a lot)
|
Weekly during intervention phase; one month follow up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kate N Harvey, PhD, University of Reading
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UREC 21/27
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on OCD
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); New York University; New York State... and other collaboratorsRecruiting
-
University of MinnesotaU.S. National Science FoundationCompleted
-
Boston University Charles River CampusNot yet recruiting
-
University of Sao PauloCompleted
-
University of FloridaInternational OCD FoundationRecruiting
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...Unknown
-
University of MinnesotaNational Institute of Mental Health (NIMH)Completed
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...Recruiting